Icon

AGGRASTAT - (12.5mg/250ml; Injection)

TIROFIBAN HYDROCHLORIDE Medicure Inc.
12.5mg/250ml; Injection
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Used to prevent blood clots that can cause a heart attack or other serious blood flow problems.
Yes
***** ****** ** ***. ***** ****** ***** * **** ** ** ****** ******* (*** *, ****) *** *** *********. *****, ***** ***** **** ***** ****** ********* '*** ******. ********** ******* **** ***** ****** *** ********* ** **********, ** *** ****** ******* ********* ** ** ** ***** *, ****. ****, ***** ****** ***** * **** ** ** '*** ****** *** *** *********. ** ****** **** **** ***** ****** **** ****** ** **** ****. ***** ****** **** ** ****** '*** *** ******** ******* **** ***** ****** ** ***** *******. ********* ** **********, ***** ****** *** ****** *** *******(**.* ** ********) ** *** *, ****. *****, ********* ***** * **** ** *** *** *********.
AGGRASTAT Patent 1 Patent 2
***** ****** ******* ******* ***** **** ** **
***** ****** ******* ******* ***** **** ** **
********* *** ********* ********* ** **** ***
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** ****** *** \ ** *** **, **** **** ******* ***** ***** ****** **** ** ** ******** ******** ** *** **, ****
***** ****** ** \ ** *** *, **** **** *******/ **** ** ** ******** *** ****** *******
********* ** \ ** *** **, **** ********* ** **** *** ******** ******** ** *** **, ****
  1. *** **, **** : ******** ***** * **** ******* ***** ****** **** ****** ******* (*** *, ****) ** ** ** *** ******.
  2. *** **, **** : ***** ***** **** ******* (*** *, ****) ****** *** ********* ** ***********. ********** ******* **** ***** ****** *** ********* ** **********, ** *** ****** ******* ********* ** ** ** ***** *, ****
  3. *** *, **** : ******** ***** * **** ******* ***** ****** **** ****** ******* (*** *, ****) ** ** ** *** ******.
  4. *** **, **** : ***** ****** **** ** ****** '*** *** ** ******* **** ******** . ********* ** **********, ***** ****** *** ****** *** ******* ** *** *, ****
  5. *** **, **** : ******** ***** * **** ******* ********* ** ****** '***.
  6. *** **, **** : ********* ********* *** **** ** *********** ** ****** '*** ** **** ***.

AGGRASTAT - (5 mg/100 ml; Injection)

TIROFIBAN HYDROCHLORIDE Medicure Inc.
5 mg/100 ml; Injection
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Aggrastat is indicated for the prevention of early myocardial infarction in adult patients presenting with acute coronary syndromes without ST elevation (NSTE-ACS) with the last episode of chest pain occurring within 12 hours and with ECG changes and/or elevated cardiac enzymes.
Yes
***** ****** ** ***. ***** ****** ***** * **** ** ** '*** ****** *** *** *********. ** ****** **** **** ***** ****** **** ****** ** **** ****. ***** **** ** ****** '*** *** ******* **** ******** ** ***** *******. ********* ** **********, ***** ****** *** ****** *** *******(* ** ********) ** *** *, ****. *****, ********* ***** * **** ** *** *** *********.
AGGRASTAT Patent 1 Patent 2
***** ****** ******* ******* ***** **** ** **
********* *** ********* ********* ** **** ***
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** ****** *** \ ********* *** *, **** **** ******* ***** ***** ****** **** ** ** ******** *** ****** *******
********* ** \ ** *** **, **** ********* ** **** *** ******** ******** ** *** **, ****
  1. *** *, **** : ******** ***** * **** ******* ***** ****** **** ****** ******* (*** *, ****) ** ** ** *** ******.
  2. *** **, **** : ***** ****** **** ** ****** '*** *** ** ******* **** ******** . ********* ** **********, ***** ****** *** ****** *** ******* ** *** **, ****
  3. *** **, **** : ******** ***** * **** ******* ********* ** ****** '***.
  4. *** **, **** : ********* ********* *** **** ** *********** ** ****** '*** ** **** ***.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.